对比增强数字乳腺摄影中假阳性与真阳性表现的比较
本研究回顾性纳入2013年1月至2018年12月接受基线筛查CEDM且BI-RADS 0、3、4、5类并活检或随访2年的女性,比较假阳性与真阳性病灶的影像特征;真阳性更常见于低能量图与碘图均可见的病灶,且低能量图表现为不对称或钙化、伴超声或MRI相关发现时恶性率更高。
要点
- 低能量图有表现且碘图有强化、或超声/MRI有对应发现的病灶,真阳性可能性更高。
- 低能量图表现为钙化或不对称且伴强化时,真阳性率高于肿块或结构扭曲。
- 半数真阳性病灶仅碘图有强化而低能量图无表现。
核心结论
- 低能量图表现伴强化、或伴超声/MRI对应发现的病灶提示真阳性;伴强化的钙化恶性率高;但半数真阳性病灶仅碘图强化而低能量图无表现。
研究设计与样本
- 回顾性研究,纳入2013年1月至2018年12月接受基线筛查CEDM且评为BI-RADS 0、3、4或5类并活检有病理诊断或完成2年影像随访的女性157例(中位年龄52岁)。
关键影像表现/征象
- 26个真阳性病灶中,1个(4%)仅低碘图像有乳腺摄影表现,13个(50%)仅碘图有对比强化表现,12个(46%)低能量图有乳腺摄影表现且碘图有对比强化表现。
- 25个假阳性钙化中24个无乳腺摄影强化,5个真阳性钙化中4个有乳腺摄影强化。
诊断标准与关键数值
- 真阳性病灶定义为活检结果为恶性的病灶;假阳性病灶定义为活检为良性或良性高风险病理、或2年影像随访阴性的病灶。
- 低能量图与碘图均可见的病灶真阳性率31%,高于仅低能量图可见的4%或仅碘图可见的12%(p = .02)。
- 低能量图与碘图均可见的病灶中,乳腺摄影表现为不对称者真阳性率46%、钙化者80%,高于肿块者11%或结构扭曲者0%(p < .001)。
- 有超声对应发现的病灶真阳性率36%,高于无超声对应发现的9%(p = .01);有MRI对应发现的病灶真阳性率18%,高于无MRI对应发现的2%(p = .02)。
临床应用与阅片要点
- 低能量图有表现且伴强化、或伴超声/MRI对应发现的病灶,阅片时应考虑真阳性可能。
- 伴强化的钙化恶性率高,需结合强化表现评估。
- 半数真阳性病灶仅碘图强化而低能量图无表现,读片时不应仅凭低能量图无表现而忽略碘图强化灶。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Contrast-enhanced digital mammography (CEDM) has been shown to outperform standard mammography while performing comparably to contrast-enhanced MRI. OBJECTIVE. The purpose of our study was to compare imaging characteristics of false-positive and true-positive findings on CEDM. METHODS. This retrospective study included women who underwent baseline screening CEDM between January 2013 and December 2018 assessed as BI-RADS category 0, 3, 4, or 5 and who underwent biopsy with histopathologic diagnosis or had a 2-year imaging follow-up. Lesion characteristics were extracted from CEDM reports. A true-positive finding was defined as a lesion in which biopsy yielded malignancy. A false-positive finding was defined as a lesion in which biopsy yielded benign or benign high-risk pathology or in which 2-year imaging follow-up was negative. RESULTS. Of 157 patients (median age, 52 years), 24 had a total of 26 true-positive lesions, and 133 had a total of 147 false-positive lesions. Of the 26 true-positive lesions, one (4%) exhibited only a mammographic finding on low-iodine images, 13 (50%) exhibited only a contrast finding on iodine images, and 12 (46%) exhibited both a mammographic finding on low-energy images and a contrast finding on iodine images. A true-positive result was more likely (p = .02) for lesions present on both low-energy images and iodine images (31%) than on low-energy images only (4%) or iodine images only (12%). Among lesions present on both low-energy and iodine images, a true-positive result was more likely (p < .001) when the type of mammographic finding was an asymmetry (46%) or calcification (80%) than a mass (11%) or distortion (0%). A true-positive result was more likely (p = .01) among those with, versus those without, an ultrasound correlate (36% vs 9%) and also was more likely (p = .02) among those with, versus those without, an MRI correlate (18% vs 2%). Of 25 false-positive calcifications, 24 had no associated mammographic enhancement; of five true-positive calcifications, four had mammographic enhancement. CONCLUSION. A low-energy mammographic finding with associated enhancement or a finding with a sonographic or MRI correlate predicts a true-positive result. Calcifications with associated enhancement had a high malignancy rate. Nonetheless, half of true-positive lesions enhanced on iodine images without a mammographic finding on low-energy images. CLINICAL IMPACT. These observations inform radiologists' management of abnormalities detected on screening CEDM.
引用
- Amir, Hogan, Jacobs, et al. Comparison of False-Positive Versus True-Positive Findings on Contrast-Enhanced Digital Mammography. AJR Am J Roentgenol. 2021. PMID: 34817195. doi:10.2214/AJR.21.26847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。